{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:56:37Z","timestamp":1790722597469,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41391-026-01095-7","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:25:03Z","timestamp":1772821503000},"page":"717-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Natural history of untreated prostate cancer: a comprehensive review of long-term progression patterns and survival outcomes"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3146-4524","authenticated-orcid":false,"given":"Ashutosh. K.","family":"Tewari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Mehrazin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wiklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micheal","family":"DeMeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2558-7306","authenticated-orcid":false,"given":"Steven A.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5815-7196","authenticated-orcid":false,"given":"Alexis E.","family":"Te","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"1095_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"1095_CR2","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2018.3710","volume":"319","author":"DC Grossman","year":"2018","unstructured":"Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, et al. Screening for prostate cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018;319:1901\u20131913.","journal-title":"JAMA"},{"key":"1095_CR3","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S0140-6736(96)09380-4","volume":"349","author":"GL Lu-Yao","year":"1997","unstructured":"Lu-Yao GL, Yao SL. Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet. 1997;349:906\u2013910.","journal-title":"Lancet"},{"key":"1095_CR4","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.3747\/co.v17i0.713","volume":"17","author":"L Klotz","year":"2010","unstructured":"Klotz L. Active surveillance for prostate cancer: patient selection and management. Curr Oncol. 2010;17:S11\u2013S17.","journal-title":"Curr Oncol"},{"key":"1095_CR5","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.eururo.2012.05.072","volume":"62","author":"MA Dall\u2019Era","year":"2012","unstructured":"Dall\u2019Era MA, Albertsen PC, Bangma C, Carroll PR, Carter HB, Cooperberg MR, et al. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol. 2012;62:976\u2013983.","journal-title":"Eur Urol"},{"key":"1095_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrurol.2015.313","volume":"13","author":"SM Bruinsma","year":"2016","unstructured":"Bruinsma SM, Bangma CH, Carroll PR, Leapman ML, Rannikko A, Petrides V, et al. Active surveillance for prostate cancer: a narrative review of clinical guidelines. Nat Rev Urol. 2016;13:151\u2013167.","journal-title":"Nat Rev Urol"},{"key":"1095_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/jama.1997.03540300035030","volume":"277","author":"JE Johansson","year":"1997","unstructured":"Johansson JE, Holmberg L, Johansson S, Bergstr\u00f6m R, Adami HO. Fifteen-year survival in prostate cancer: a prospective, population-based study in Sweden. JAMA. 1997;277:467\u2013471.","journal-title":"JAMA"},{"key":"1095_CR8","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1001\/jama.293.17.2095","volume":"293","author":"PC Albertsen","year":"2005","unstructured":"Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA. 2005;293:2095\u20132101.","journal-title":"JAMA"},{"key":"1095_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1001\/jama.2009.1348","volume":"302","author":"GL Lu-Yao","year":"2009","unstructured":"Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, et al. Outcomes of localized prostate cancer following conservative management. JAMA. 2009;302:1202\u20131209.","journal-title":"JAMA"},{"key":"1095_CR10","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1056\/NEJMoa1311593","volume":"370","author":"A Bill-Axelson","year":"2014","unstructured":"Bill-Axelson A, Holmberg L, Garmo H, Rider JR, Taari K, Busch C, et al. Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med. 2014;370:932\u2013942.","journal-title":"N Engl J Med"},{"key":"1095_CR11","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJMoa012794","volume":"347","author":"L Holmberg","year":"2002","unstructured":"Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, H\u00e4ggman M, et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med. 2002;347:781\u2013789.","journal-title":"N Engl J Med"},{"key":"1095_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1056\/NEJMoa1615869","volume":"377","author":"TJ Wilt","year":"2017","unstructured":"Wilt TJ, Jones KM, Barry MJ, Andriole GL, Culkin D, Wheeler T, et al. Follow-up of prostatectomy versus observation for early prostate cancer. N Engl J Med. 2017;377:132\u2013142.","journal-title":"N Engl J Med"},{"key":"1095_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","volume":"33","author":"L Klotz","year":"2015","unstructured":"Klotz L, Vesprini D, Sethukavalan P, Jethava V, Zhang L, Jain S, et al. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol. 2015;33:272\u2013277.","journal-title":"J Clin Oncol"},{"key":"1095_CR14","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1200\/JCO.2011.34.9738","volume":"29","author":"MR Cooperberg","year":"2011","unstructured":"Cooperberg MR, Carroll PR, Klotz L. Active surveillance for prostate cancer: progress and promise. J Clin Oncol. 2011;29:3669\u20133676.","journal-title":"J Clin Oncol"},{"key":"1095_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T","volume":"72","author":"J Adolfsson","year":"1993","unstructured":"Adolfsson J, Steineck G, Whitmore WF Jr. Recent results of management of palpable clinically localized prostate cancer. Cancer. 1993;72:310\u2013322.","journal-title":"Cancer"},{"key":"1095_CR16","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1097\/PAS.0b013e3182556dcd","volume":"36","author":"HM Ross","year":"2012","unstructured":"Ross HM, Kryvenko ON, Cowan JE, Simko JP, Wheeler TM, Epstein JI. Do adenocarcinomas of the prostate with Gleason score \u22646 have the potential to metastasize to lymph nodes? Am J Surg Pathol. 2012;36:1346\u20131352.","journal-title":"Am J Surg Pathol"},{"key":"1095_CR17","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/S0090-4295(00)00791-3","volume":"56","author":"WA Sakr","year":"2000","unstructured":"Sakr WA, Tefilli MV, Grignon DJ, Banerjee M, Dey J, Gheiler EL, et al. Gleason score 7 prostate cancer: a heterogeneous entity? Correlation with pathologic parameters and disease-free survival. Urology. 2000;56:730\u2013734.","journal-title":"Urology"},{"key":"1095_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJMoa032975","volume":"351","author":"AV D\u2019Amico","year":"2004","unstructured":"D\u2019Amico AV, Chen MH, Roehl KA, Catalona WJ. Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy. N Engl J Med. 2004;351:125\u2013135.","journal-title":"N Engl J Med"},{"key":"1095_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/jnci\/djp001","volume":"101","author":"G Draisma","year":"2009","unstructured":"Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst. 2009;101:374\u2013383.","journal-title":"J Natl Cancer Inst"},{"key":"1095_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969\u2013974.","journal-title":"JAMA"},{"key":"1095_CR21","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/jnci\/djj410","volume":"98","author":"HB Carter","year":"2006","unstructured":"Carter HB, Ferrucci L, Kettermann A, Landis P, Wright CH, Epstein JI, et al. Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability. J Natl Cancer Inst. 2006;98:1521\u20131527.","journal-title":"J Natl Cancer Inst"},{"key":"1095_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.eururo.2012.10.002","volume":"63","author":"M Popiolek","year":"2013","unstructured":"Popiolek M, Rider JR, Andr\u00e9n O, Andersson SO, Holmberg L, Adami HO, et al. Natural history of early, localized prostate cancer: a final report from three decades of follow-up. Eur Urol. 2013;63:428\u2013435.","journal-title":"Eur Urol"},{"key":"1095_CR23","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1002\/cncr.26104","volume":"117","author":"TJ Daskivich","year":"2011","unstructured":"Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S, et al. Comorbidity and competing risks for mortality in men with prostate cancer. Cancer. 2011;117:4642\u20134650.","journal-title":"Cancer"},{"key":"1095_CR24","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1056\/NEJM199401273300403","volume":"330","author":"GW Chodak","year":"1994","unstructured":"Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med. 1994;330:242\u2013248.","journal-title":"N Engl J Med"},{"key":"1095_CR25","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","volume":"375","author":"FC Hamdy","year":"2016","unstructured":"Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375:1415\u20131424.","journal-title":"N Engl J Med"},{"key":"1095_CR26","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","volume":"360","author":"FH Schr\u00f6der","year":"2009","unstructured":"Schr\u00f6der FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320\u20131328.","journal-title":"N Engl J Med"},{"key":"1095_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-025-01032-0","author":"R Rosato","year":"2025","unstructured":"Rosato R, De Luca S, Zitella A, Munoz F, Baima CG, Barale M, et al. Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study. Prostate Cancer Prostatic Dis. 2025. https:\/\/doi.org\/10.1038\/s41391-025-01032-0.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1095_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41391-024-00822-2","volume":"28","author":"C Desmond","year":"2025","unstructured":"Desmond C, Kaul S, Fleishman A, Korets R, Chang P, Wagner A, et al. The association of patient and disease characteristics with the overtreatment of low-risk prostate cancer from 2010 to 2016. Prostate Cancer Prostatic Dis. 2025;28:385\u2013393.","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01095-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01095-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01095-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:00:22Z","timestamp":1790719222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01095-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1095"],"URL":"https:\/\/doi.org\/10.1038\/s41391-026-01095-7","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}